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Abstract: Numerous approaches have been employed to treat chronic lymphocele and cutaneous lym-
phatic fistulas (LFs) with little success. Given a high incidence and substantial consequences for patients,
there is an ongoing demand for effective therapeutic and preventive strategies. The aim of this study
was to evaluate the results after microscopic lymphatic ligation (MLL) and lymphovenous anastomosis
(LVA) as a therapeutic and preventive approach in this context. Methods Demographic data, surgical
characteristics, complications, and the overall outcome of all patients undergoing surgery for postopera-
tive LF from 2014 to 2019 were collected retrospectively. Patients were categorized in accordance with
predefined inclusion/exclusion criteria and with their treatment. Statistical analysis was conducted using
descriptive, summary statistics to identify a central tendency. Results Thirty-four patients underwent
indocyanine-green-lymphangiography guided revision surgery for LF. Two patients were lost to follow-up
at 6 months. LF was successfully treated in all patients (n = 32) with a multimodal approach. Only
MLL was performed in 22 patients and MLL/LVA in 10 patients. LF resolved in 78% of all patients
with MLL only or MLL/LVA. In the remaining 22%, LF resolved after additional sclerotherapy within
3 months. Conclusions Treatment of LF should follow a standardized staged surgical approach to op-
timize outcome. LF was treated successfully in all our patients. We therefore propose a multimodal
interdisciplinary approach to this common clinical problem that includes adjunctive sclerotherapy.
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INTRODUCTION
The exact pathophysiology of postoperative chronic 
fluid accumulation has been vague for decades. The term 
seroma was historically given to describe this frequent phe-
nomenon and a multifactorial causality was acknowledged. 
Studies have shown that the fluid is in fact an accumula-
tion of lymphatic fluid deriving from severed afferent lym-
phatics at the site where tissue was removed accumulating 
initially in a nonepithelialized cavity.1,2 Postoperative lym-
phatic fistulas (LFs) can result whenever lymphatic vessels 
are injured during surgical dissection. They present either 
as cutaneous fistula with lymphorrhea or as a collection of 
lymph accumulating initially in a nonepithelialized cavity 
referred to as lymphocele. A closed lymphocele can evolve 
into a cutaneous LF, if wound breakdown occurs. Some LFs 
resolve spontaneously, whereas others become chronic. 
Anatomical studies reveal that divergent and alternative 
lymphatic drainage pathways exist.3,4 Differences in ves-
sel depth or vessel diameter may be contributing factors 
favoring transport through 1 vessel over another and thus 
leading to a prolonged leakage in some cases.5
Although after sentinel-lymph node biopsy (SLNB) the 
formation of a symptomatic lymphocele appears to be less 
than 7%, incidences following lymphadenectomy (LAD), 
in particular of the groin, are higher and are reported 







Background: Numerous approaches have been employed to treat chronic lym-
phocele and cutaneous lymphatic fistulas (LFs) with little success. Given a high 
incidence and substantial consequences for patients, there is an ongoing demand 
for effective therapeutic and preventive strategies. The aim of this study was to 
evaluate the results after microscopic lymphatic ligation (MLL) and lymphovenous 
anastomosis (LVA) as a therapeutic and preventive approach in this context.
Methods: Demographic data, surgical characteristics, complications, and the over-
all outcome of all patients undergoing surgery for postoperative LF from 2014 to 
2019 were collected retrospectively. Patients were categorized in accordance with 
predefined inclusion/exclusion criteria and with their treatment. Statistical analysis 
was conducted using descriptive, summary statistics to identify a central tendency.
Results: Thirty-four patients underwent indocyanine-green-lymphangiography 
guided revision surgery for LF. Two patients were lost to follow-up at 6 months. 
LF was successfully treated in all patients (n = 32) with a multimodal approach. 
Only MLL was performed in 22 patients and MLL/LVA in 10 patients. LF resolved 
in 78% of all patients with MLL only or MLL/LVA. In the remaining 22%, LF 
resolved after additional sclerotherapy within 3 months.
Conclusions: Treatment of LF should follow a standardized staged surgical approach 
to optimize outcome. LF was treated successfully in all our patients. We therefore 
propose a multimodal interdisciplinary approach to this common clinical problem 
that includes adjunctive sclerotherapy. (Plast Reconstr Surg Glob Open 2021;9:e3407; 
doi: 10.1097/GOX.0000000000003407; Published online 18 February 2021.)
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tumor, incidences range between 10% and 36% and reach 
almost 100% after extended soft-tissue resections in the 
proximal medial thigh.9 Predictive factors include the 
amount of excised tissue as well as adjuvant chemotherapy 
and/or radiotherapy of the operating site.10
In addition, LF is associated with further complications 
such as wound breakdown, infection of the operating site 
including underlying vascular grafts or other prostheses, 
prolonged treatment duration, recurrent hospitalization, 
lymphangitis, fever, and sepsis.10,11 Muscle flaps are efficient 
in dead space reduction and thus assist in the prevention 
of chronic postoperative fluid accumulation but do not 
address the fistula itself.7,11 Various other approaches have 
been introduced to prevent and treat LF without scientific 
evidence such as drainage systems, compression dress-
ings, quilting sutures, fibrin glue and repeated percutane-
ous aspirations, embolization, or injection of sclerosants. 
However, in high-risk cases, for example, patients under 
immunosuppressive medication or reduced wound-heal-
ing ability due to radiotherapy, conservative treatment is 
known to be less effective and can even increase morbidity.
In the era of lymphatic supermicrosurgery, modern 
therapeutic approaches include investigation of the 
wound bed with Indocyanine-Green (ICG) lymphog-
raphy to detect severed lymphatic vessels.12 Selective 
ligation of lymph vessels for the treatment of recur-
rent inguinal LF using titanium clips or nonabsorbable 
sutures appears to be an appropriate treatment modality 
in small-scale reports.13,14 The successful use of recon-
structive lymphatic microsurgery has been described as a 
more physiologic option in a limited number of patients 
with LF so far and may provide more reliable results.15–17 
However, not all patients are suitable for lymphatic 
reconstruction since lymphatics may not be suitable for 
anastomosis due their size or quality and venules may not 
always be available.
Therefore, the purpose of this study is to evaluate the 
outcomes of microscopic lymphatic ligation (MLL) and 
lymphovenous anastomosis (LVA) for the treatment of LF. 
We propose a comprehensive treatment algorithm with a 
multimodal interdisciplinary approach.
MATERIALS AND METHODS
The approval for this study was granted by the Cantonal 
Ethics Committee of Zurich, Switzerland (BASEC-Nr. 
2019-00841).
Surgical Technique and Algorithm
In our unit, a standardized interdisciplinary approach 
in cooperation with the interventional radiologists was 
developed since 2014 to provide a clear treatment algo-
rithm for patients with postoperative LF depending on 
wound status (open/closed) and the presence of immu-
nosuppression (Fig.  1). This algorithm has been used 
increasingly in our unit over the past 5 years and our 
sclerotherapy protocol has been published recently.18
The diagnosis for postoperative LF was made by clini-
cal examination only and treatment was offered whenever 
it became symptomatic by size and patient reported dis-
comfort. If the surgical wound remains closed, sclerother-
apy is preferred as a first approach after 3 unsuccessful 
attempts of percutaneous fluid aspirations. We proceed to 
revision surgery directly in the case of wound breakdown 
or if the patient is immunosuppressed, for example, after 
heart transplantation and resect epithelialized cavities if 
present. In the setting of cutaneous LF or infection, antibi-
otics are given and staged debridement with negative pres-
sure wound therapy is applied. During the final revision 
Fig. 1. Flowchart on the standardized staged surgical approach depending on wound status (open/
closed) and the presence of immunosuppression in patients with postoperative lF.
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surgery, the wound bed is examined meticulously under 
the microscope guided by ICG to investigate the existence 
of leaking lymphatic vessels (Figs. 2 and 3). (See Video 1 
[online], which displays an intraoperative video of chronic 
LF with visible lymphorrhea.)
We prefer to implement end-to-end LVA whenever pos-
sible and combine it with MLL using microtitanium clips. 
During surgery, 0.2–0.3 ml of ICG is injected intradermally 
in the dorsal interdigital spaces I–IV of hand or foot and, 
in addition, above the elbow/knee or around the wound 
depending on the localization. Severed lymphatic vessels 
and subsequent lymphatic leakage are detected by ICG-
angiography using a high-resolution fluorescent micro-
scope (OPMI Pentero, Zeiss, Germany) (Fig.  2). (See 
Video 2 [online], which displays intraoperative video (flu-
orescence mode) of ICG-leakage of the same lymphatic 
fistula, which will make it easier to detect.) If a suitable 
vein is available, LVA is performed using an end-to end 
technique with Nylon 11-0 or 12-0 interrupted sutures. 
Unfortunately, wounds are often scarred after numer-
ous operations and attempts of sclerotherapy and a vein 
may not be available. In these cases, we perform selective 
microscopic ligations with microtitanium clips. A flap usu-
ally was always added if impaired wound healing can be 
expected due to the size of the skin defect or if the soft-
tissue coverage is insufficient. A Blake drain is placed and 
kept for at least 10–14 days to allow for sufficient wound 
healing. We ideally remove the drain when discharge is 
less than 20 ml/d. Bed rest is required for 3 days postop-
eratively. Patients are discharged after 5 days the earliest 
and depending on wound and general condition either 
with or without drain. Amoxicillin 1 g twice daily is given as 
long as the drain is in place and antibiotics are constantly 
adapted according to microbiologic specimen results. 
Patients are advised physical activity restriction for a total 
of 14–21 days and are usually followed up to 12 month 
postoperatively in an ambulatory setting. If minor LF per-
sists after revision surgery, additional sclerotherapy is per-
formed. We usually wait 3–4 weeks after MLL/ LVA before 
referring patients to sclerotherapy.18
Study Design and Patients
This retrospective analysis included a review of 150 
operation reports and clinical follow-up data of all male and 
female patients (>18 years) who underwent revision sur-
gery for LF between January 2014 and April 2020. Patients 
who did not receive ICG-lymphangiography were excluded 
from this study. LFs were refractory to conservative or 
interventional management for at least 4 weeks. Patients 
were excluded if they did not consent for retrospective 
data analysis or if the institutional informed consent was 
missing. Other exclusion criteria were preexisting severe 
skin diseases such as atopic dermatitis or acne inversa, 
concomitant oncologic chemotherapy or concomitant 
Fig. 2.  Surgical treatment of chronic lymphocele. a, intraoperative situs of a patient with a high-flow fistula (300–500 ml/d) after lymph 
node biopsy in the right groin. B, intraoperative icg-lymphangiography of the situs showing lymphatic leakage. c, intraoperative view of 
an injured lymphatic vessel with high flow under the microscope. D, lymphovenous anastomosis of the severed lymphatic vessel to an 
adjacent vein. e, intraoperative icg-lymphangiography confirmed patency of the lymphovenous anastomosis.
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radiotherapy, ongoing intravenous drug abuse, and revi-
sion surgery without special consideration given to lym-
phatics. Patients were further categorized according to 
their treatment in 2 cohorts: MLL and MLL combined 
with lymphatic reconstruction. All patients were operated 
by the senior author (N.L.). Demographic data, surgical 
characteristics and complications, as well as the overall out-
come of treatment were abstracted from patients’ comput-
erized charts and electronic records and are presented in 
a descriptive manner. Lymphedema was monitored clini-
cally. Diagnosis was based on signs and symptoms, and the 
International Society of Lymphology Staging System is our 
method of choice to further classify lymphedema along 
with imaging modalities. We document all signs that may 
be subjective observations of our ambulatory patients such 
as a feeling of heaviness in the affected extremity.
Statistical Analysis
Statistical analysis was conducted in a descriptive man-
ner. Data were analyzed using Microsoft Excel Version 
14.3.6. (Microsoft Corp., Redmond, Wash.). This study was 
conducted according to the Strengthening the Reporting 
of Observational studies in Epidemiology (STROBE) 
guidelines.
RESULTS
Thirty-four patients undergoing ICG-lymphangio- 
graphy–guided revision surgery between January 2014 
and April 2020 were included, and 2 patients were lost to 
follow-up. A flowchart of patients reporting on the num-
bers of individuals at each stage of study is provided in 
Figure 4.
Main Causes for LF Development
The primary causes for LF were vascular cannulation 
for extracorporeal membrane oxygenation (n = 11), other 
vascular access procedures/vein harvest (n = 8), lymph 
node biopsy/lymph node dissection (n = 7), dermoli-
pectomy (n = 3), soft-tissue tumor resection (n = 3), flap 
donor site (n = 1), and knee prosthesis procedure (n = 1). 
The LF was located at the groin and medial thigh in 31 
patients, the neck in 2 patients, and abdominal (subcuta-
neous) in 1 patient.
Demographics and Results in Summary
Patients were pretreated in accordance with our pre-
viously described standardized staged surgical approach 
depending on wound status (open/closed) and presence 
of immunosuppression. Two patients were lost to follow 
up after revisional surgery for LF and were excluded from 
further analysis: One patient in the MLL cohort had a per-
sistent low-grade infection of his femoral vascular graft and 
had to be operated on by vascular surgeons before and 
after our revision surgery. After a 3-month consultation 
with an ongoing LF, the patient unfortunately never pre-
sented again at our department. Another severely immu-
nosuppressed patient with persisting LF after LVA and 
MLL died within the study period. Eventually, 32 patients 
with persistent LF were included into further analysis.
Mean age was 61 ± 16 years. Mean body mass index 
was 29 ± 6 kg/m2. None of the patients had preoperative 
signs and symptoms of secondary lymphedema before 
treatment. Twenty-eight percent (9/32) patients were 
immunosuppressed. All patients received perioperative 
antibiotic therapy.
The mean follow-up period was 11 months. Twenty-
seven of 32 patients were followed up at 12 months and 
4 patients were followed up at 6 months postoperatively. 
One patient was followed up at 3 months postoperatively 
and is expected to return for further follow-ups.
In summary, LF was successfully treated in all patients 
(n = 32) (Fig.  1; Table  1). LF resolved in 78% (25/32) 
of all patients with MLL only or MLL with LVA. In the 
remaining 22% (7/32), LF resolved after additional 
Fig. 3. intraoperative situs with Mlls and lymphovenous anasto-
mosis (black arrow). the 0.2-mm titanium microclips and 10-0 nylon 
sutures were used.
Fig. 4. Flowchart of patients reporting on selection and numbers of individuals.
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sclerotherapy after 1.5 months and (range 1–3) in 2.5 
sclerotherapy sessions on average (range 1–4). MLL alone 
was conducted in 22 and MLL was combined with LVA in 
10 patients.
MLL Only
Twenty-two patients with postoperative LF were treated 
with MLL without perioperative complications. Mean fol-
low-up period was 11 months. Six out of 22 patients (27%) 
were immunosuppressed. In 6 out of the 22 cases, addi-
tional muscle flaps were performed. In 2 out of 22 cases, 
a major tissue defect was reconstructed with a pedicled 
anterolateral thigh fasciocutaneous flap. Although 82% 
(18/22) of all patients were successfully treated with MLL, 
18% (4/22) underwent further secondary sclerotherapy 
(Fig. 5). None of them had to be reoperated on due to sur-
gical site infection or major wound breakdown (Table 1). 
We did not see any secondary lymphedema in this cohort 
after treatment.
MLL and LVA
In 10 patients, LVAs were performed in combination 
with MLL without perioperative complications (Table 2). 
In total, 14 LVAs were performed (Table 3). Mean follow-
up period was 11 months. Three out of 10 patients (30%) 
were immunosuppressed. One patient received a pedicled 
muscle flap and 1 patient received a chimeric pedicled 
flap. Although 70% (7/10) of all patients were successfully 
treated with LVA in combination with MLL, 30% (3/10) 
underwent further secondary sclerotherapy (Fig. 5). One 
patient developed a postoperative hematoma and had to 
be operated emergently. This patient developed transient 
lymphedema at 6 month that was not apparent after 12 
months postoperatively.
DISCUSSION
Different concepts about the anatomical characteris-
tics of the lymphatic system exist in an attempt to explain 
why LF becomes chronic in some patients. In the lower 
limbs, there are 2 major routes of lymphatic flow. Their 
distribution is similar to veins of the lower limb and can be 
divided into 2 major groups: superficial vessels and deep 
vessels. Furthermore, cadaver studies demonstrate that 
the lymphatic vessels of the thigh form 3 layers: the first 
layer, immediately below the surface of the subcutaneous 
fat; the second layer, between the first and third layers; 
and the third layer, on the deep fascia.19,20 The medial 
aspect of the thigh in particular contains rich vertical 
lymphatic vessels.20 According to the concept of lympho-
somes, superficial lymphatic vessels diverge and merge on 
their way to the lymph node and do not cross each other 
in humans, demarking and dividing the skin into certain 
lymphatic territories, which are referred to as lympho-
somes.21 Preferential lymphatic drainage patterns seem to 
exist such that for a given tissue space, fluid drainage is 
the primary responsibility of one single vessel, whereas any 
additional vessels in the area serve as overflow or reserve 
transport routes for large fluid loads.22 If these connec-
tions are not present and/or high-flow afferent lymphatic 
vessels are injured, LF might be promoted. Multiple stud-
ies show that supermicrosurgical lymphatic reconstruction 
is effective for creating new lymphatic pathways enabling 
the smooth flow of lymph fluid from the affected area 
to the trunk.15–17,23 The saphenous vein is often resected 
during LAD and soft-tissue tumor resections of the upper 
medial thigh. The anatomy of the venous system of the 
thigh still allows the implementation of intralesional LVA 
as superficial veins perforate the deeper layer and connect 
with the deep venous systems.
Macroscopic ligation of lymphatic vessels bears the risk 
of subsequent clinical lymphedema because the normal 
lymphatic drainage function may be impaired and is there-
fore not recommended.24 Additionally, macroscopic liga-
tion often does not actually close the microscopic severed 
lymphatic vessel. Selective MLL under the fluorescence 
microscope using microtitanium clips as well as lymphatic 
mapping and ligation of severed lymph vessels with nonab-
sorbable sutures have been described to be useful for the 
treatment of refractory LF.14,25 In the case of a high lymphatic 
upload through a main pathway producing high pressure, 
simple ligation might come off or loosen. Therefore, LVA 
might be superior to MLL alone, if possible, because these 
will reduce the pressure within the lymphatic system and 
allow a physiological drainage of the severed lymphatic ves-
sel into the venous system. Other studies have described 
LVA for LF15–17,23,26–28 demonstrating successful treat-
ment by LVA in patients with pelvic LF after gynecologic 
Fig. 5. Subanalysis regarding need for additional secondary sclerotherapy in patients receiving Mll only 
and Mll and lVa.
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cancer treatment combined with lymphocele capsule resec-
tion and in patients with LF after SLNB. One patient with 
chronic LF after inguinal hernia repair was treated success-
fully by surrounding LVA for chronic groin lymphocele 
treatment.28 In our experience, the main advantage of per-
forming LVA over MML is that the fistula usually is treated 
more reliably as the technique addresses the physiology of 
the condition directly. One danger of clipping only may be 
that the clips fall off during wound healing and the fistula 
returns. Reconstruction of alternative drainage pathways 
for severed lymphatics will be the better option than just 
ligating those and should be the primary goal. Results may 
be more stable and the risk of lymphedema might be lower. 
However, not all patients are suitable for LVA, especially 
in the case of chronic LF, in which the patients was usu-
ally been operated many times and the tissue is extremely 
scarred. Lymphatics may be too small in caliber or fibrotic, 
and there may be no appropriate venules in close proxim-
ity. We therefore propose to use both techniques to treat LF.
Some authors claim that extralesional LVA/LLA have 
similar effects compared to intralesional LVA/LLA.15,28 
So far, there is no evidence that all patients benefit from 
this technique. Moreover, there is a considerable risk of 
developing secondary lymphedema following these proce-
dures. We did not perform extralesional LVA/LLA since 
we believe that these should be preserved for patients with 
a preexisting lymphedema. We also did not treat patients 
with concomitant lymphedema, whereas the whole patient 
collective described by Giacalone et al15 had lymphedema 
before treatment. None of our patients had lymphedema 
before the treatment and none developed manifest lymph-
edema at the end of follow-up. Our mean follow-up time 
was 11 months, and most patients were followed up at 12 
months postoperatively. Only 1 patient developed mild 
symptoms of lymphedema after LVA and MLL, which was 
transient and symptoms disappeared at 6 months. Our 
results show that MLL and LVA can safely be performed in 
patients with LF. Giacalone et al15 further have presented a 
highly homogenous patient population in contrast to our 
cohort. Furthermore, all patients were immunocompetent. 
On the contrary, the patient collective in clinical practice 
is very inhomogeneous and a patient-specific approach is 
advised (eg, immunosuppression, tissue defect, infection, 
localization, previous irradiation, etc.).
Twenty-eight percent patients were immunosuppressed 
[MLL only cohort 27% (6/22) and LVA/MLL cohort 30% 
(3/10)]. Most of the patients included into this study did 
not receive an additional flap (72%, ie, 23/32). A flap was 
usually added if impaired wound healing was suspected 
due to the size of the skin defect or if the soft-tissue cover-
age was insufficient. Especially in immunocompromised 
patients, wound healing can remain a problem even after 
LF is treated. In these cases, tissue reconstruction is neces-
sary. Eventually, the fact that wound closure is achieved at 
all is a big success in some patients. Moreover, coverage 
with a flap alone does not stop the lymphocele. It will at 
best turn the open wound with LF into a closed would with 
a LF underneath. Studies have shown that muscle flaps do 
not reduce morbidity after lymphadenectomies.7,29
In summary, we have demonstrated how diverse the col-
lective of LF patients is in daily clinical practice, and our 
numbers and demographics are mirroring the reality at our 
maximum care university hospital with a busy reconstruc-
tive surgery unit. We do not aim to confirm a definitive 
best way of treating LF as the present study design will not 
allow for such a conclusion. Based on our experiences and 
the results of this study, we recommend a multimodal and 
patient-centered strategy that may include adjunct sclero-
therapy to optimize outcomes in each individual case. MLL 
and LVA may complement each other. LF can be very dif-
ficult to manage and patients usually spent months in the 
hospitals before they finally are referred to us. Primary 
sclerotherapy alone often was not successful due to a high-
flow lymphatic fistula in these patients. The proposed algo-
rithm intends to act as a guide and assist in controlling an 
LF in a comprehensive way for a seemingly minor, but even-
tually severe problem, since no real treatment options exist, 
if sclerotherapy alone is not successful. However, sclerother-
apy may very well be useful as an adjunct therapy after surgi-
cal repair for a much smaller remaining fistula.
Another interesting aspect of our results is that although 
symptomatic axillary LF occurs in 14% of patients undergo-
ing breast-conserving surgery with SLNB, we did not see 
any patients with axillary LF.30 Management infrequently 
requires more than simple aspiration.30 An explanation 
might be that the groin is permanently exposed to shear 
stress whenever the patient ambulates, whereas the axilla 
can easily rest. In addition, a significant higher lymphatic 
flow can be expected from a leg when compared to an arm.
Some limitations apply to this study. First, the study has 
a retrospective, descriptive nature and further long-term 
follow-up data should be collected. Especially, because it is 
not possible to determine whether chronic lymphedema is 
present during a 1-year follow-up period alone. Due to lack 
in documentation, aspirated volumes, drainage output vol-
umes and lymphocele sizes could not be described. The 
effectiveness of each treatment modality and their combina-
tion as well as complication rates and side effects have to be 
tested separately and prospectively. Also, postoperative imag-
ing evaluation should be used to assess for lymphedema and 
verify the significance of cases in which an LVA could be per-
formed. In a next scientific step, we are planning a long-term 
follow-up study with a larger cohort to identify confounders 
and to compare different treatments and their efficacies.
In the present study, we have demonstrated that our stan-
dardized staged surgical approach depending on wound 
Table 3.  Number of LVA in Each Patient
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status (open/closed) and the presence of immunosuppres-
sion in patients with postoperative LF is feasible and highly 
successful at our institution. We are not aware of a study that 
discusses a staged surgical approach to LF with multiple tech-
niques complementing each other as presented here. To our 
knowledge, we report the largest cohort treated so far with 
this approach. In addition, we adopted this technique to 
lesions of the thoracic duct. LVA was successfully performed 
to reconstruct a thoracic duct transection by lymphovenous 
anastomosis of the thoracic duct to the external jugular vein 
after neck dissection for hypopharyngeal cancer.31
CONCLUSIONS
In conclusion, the treatment of LF is very challenging and 
should follow a standardized staged approach to optimize 
each patient’s outcome. LF was treated successfully in all our 
patients. We therefore strongly advise a multimodal inter-
disciplinary approach to this common clinical problem that 
includes adjunctive sclerotherapy. Reconstructive lymphatic 
supermicrosurgery should be considered as a preferred 
causal therapy. MLL remains important in combination and 
whenever reconstructive microsurgery is not feasible.
Nicole Lindenblatt, MD
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